Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
J Biol Chem
2013 Aug 02;28831:22758-67. doi: 10.1074/jbc.M113.482596.
Show Gene links
Show Anatomy links
Crystal structure of a human IκB kinase β asymmetric dimer.
Liu S
,
Misquitta YR
,
Olland A
,
Johnson MA
,
Kelleher KS
,
Kriz R
,
Lin LL
,
Stahl M
,
Mosyak L
.
???displayArticle.abstract???
Phosphorylation of inhibitor of nuclear transcription factor κB (IκB) by IκB kinase (IKK) triggers the degradation of IκB and migration of cytoplasmic κB to the nucleus where it promotes the transcription of its target genes. Activation of IKK is achieved by phosphorylation of its main subunit, IKKβ, at the activation loop sites. Here, we report the 2.8 Å resolution crystal structure of human IKKβ (hIKKβ), which is partially phosphorylated and bound to the staurosporine analog K252a. The hIKKβ protomer adopts a trimodular structure that closely resembles that from Xenopus laevis (xIKKβ): an N-terminal kinase domain (KD), a central ubiquitin-like domain (ULD), and a C-terminal scaffold/dimerization domain (SDD). Although hIKKβ and xIKKβ utilize a similar dimerization mode, their overall geometries are distinct. In contrast to the structure resembling closed shears reported previously for xIKKβ, hIKKβ exists as an open asymmetric dimer in which the two KDs are further apart, with one in an active and the other in an inactive conformation. Dimer interactions are limited to the C-terminal six-helix bundle that acts as a hinge between the two subunits. The observed domain movements in the structures of IKKβ may represent trans-phosphorylation steps that accompany IKKβ activation.
Baldwin,
Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB.
2001, Pubmed
Baldwin,
Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB.
2001,
Pubmed
Baldwin,
The NF-kappa B and I kappa B proteins: new discoveries and insights.
1996,
Pubmed
Barnes,
Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases.
1997,
Pubmed
Blanc,
Refinement of severely incomplete structures with maximum likelihood in BUSTER-TNT.
2004,
Pubmed
Burke,
BMS-345541 is a highly selective inhibitor of I kappa B kinase that binds at an allosteric site of the enzyme and blocks NF-kappa B-dependent transcription in mice.
2003,
Pubmed
Chen,
Site-specific phosphorylation of IkappaBalpha by a novel ubiquitination-dependent protein kinase activity.
1996,
Pubmed
Collaborative Computational Project, Number 4,
The CCP4 suite: programs for protein crystallography.
1994,
Pubmed
Davies,
A structural comparison of inhibitor binding to PKB, PKA and PKA-PKB chimera.
2007,
Pubmed
Deng,
Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain.
2000,
Pubmed
Dey,
Mechanistic link between PKR dimerization, autophosphorylation, and eIF2alpha substrate recognition.
2005,
Pubmed
DiDonato,
A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB.
1997,
Pubmed
Emsley,
Features and development of Coot.
2010,
Pubmed
Gerondakis,
Unravelling the complexities of the NF-kappaB signalling pathway using mouse knockout and transgenic models.
2006,
Pubmed
Goncalves,
Functional dissection of the TBK1 molecular network.
2011,
Pubmed
Hatada,
NF-kappaB and the innate immune response.
2000,
Pubmed
Huynh,
Characterization of the recombinant IKK1/IKK2 heterodimer. Mechanisms regulating kinase activity.
2000,
Pubmed
Häcker,
Regulation and function of IKK and IKK-related kinases.
2006,
Pubmed
Israël,
The IKK complex, a central regulator of NF-kappaB activation.
2010,
Pubmed
Karin,
Nuclear factor-kappaB in cancer development and progression.
2006,
Pubmed
Karin,
The I kappa B kinase (IKK) and NF-kappa B: key elements of proinflammatory signalling.
2000,
Pubmed
Kishore,
IKK-i and TBK-1 are enzymatically distinct from the homologous enzyme IKK-2: comparative analysis of recombinant human IKK-i, TBK-1, and IKK-2.
2002,
Pubmed
Krissinel,
Inference of macromolecular assemblies from crystalline state.
2007,
Pubmed
Larabi,
Crystal structure and mechanism of activation of TANK-binding kinase 1.
2013,
Pubmed
Ling,
NF-kappaB-inducing kinase activates IKK-alpha by phosphorylation of Ser-176.
1998,
Pubmed
Ma,
Molecular basis of Tank-binding kinase 1 activation by transautophosphorylation.
2012,
Pubmed
May,
A novel ubiquitin-like domain in IkappaB kinase beta is required for functional activity of the kinase.
2004,
Pubmed
Mbalaviele,
A novel, highly selective, tight binding IkappaB kinase-2 (IKK-2) inhibitor: a tool to correlate IKK-2 activity to the fate and functions of the components of the nuclear factor-kappaB pathway in arthritis-relevant cells and animal models.
2009,
Pubmed
McCoy,
Phaser crystallographic software.
2007,
Pubmed
Mercurio,
IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation.
1997,
Pubmed
Mercurio,
IkappaB kinase (IKK)-associated protein 1, a common component of the heterogeneous IKK complex.
1999,
Pubmed
Niederberger,
The IKK-NF-kappaB pathway: a source for novel molecular drug targets in pain therapy?
2008,
Pubmed
Otwinowski,
Multiparametric scaling of diffraction intensities.
2003,
Pubmed
Potterton,
Developments in the CCP4 molecular-graphics project.
2004,
Pubmed
Rushe,
Structure of a NEMO/IKK-associating domain reveals architecture of the interaction site.
2008,
Pubmed
Scheidereit,
IkappaB kinase complexes: gateways to NF-kappaB activation and transcription.
2006,
Pubmed
Schröfelbauer,
NEMO ensures signaling specificity of the pleiotropic IKKβ by directing its kinase activity toward IκBα.
2012,
Pubmed
Shimada,
IKK-i, a novel lipopolysaccharide-inducible kinase that is related to IkappaB kinases.
1999,
Pubmed
Tu,
Structure and ubiquitination-dependent activation of TANK-binding kinase 1.
2013,
Pubmed
Woronicz,
IkappaB kinase-beta: NF-kappaB activation and complex formation with IkappaB kinase-alpha and NIK.
1997,
Pubmed
Xu,
Crystal structure of inhibitor of κB kinase β.
2011,
Pubmed
,
Xenbase
Yamamoto,
Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer.
2001,
Pubmed
Yamaoka,
Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation.
1998,
Pubmed
Zandi,
The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation.
1997,
Pubmed
Zhang,
An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor.
2006,
Pubmed
Zheng,
2.2 A refined crystal structure of the catalytic subunit of cAMP-dependent protein kinase complexed with MnATP and a peptide inhibitor.
1993,
Pubmed
